BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2149042)

  • 1. Options and limitations of teicoplanin in febrile granulocytopenic patients.
    De Pauw BE; Novakova IR; Donnelly JP
    Br J Haematol; 1990 Dec; 76 Suppl 2():1-5. PubMed ID: 2149042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teicoplanin as modification of initial empirical therapy in febrile granulocytopenic patients.
    Nováková IR; Donnelly JP; Verhagen CS; De Pauw BE
    J Antimicrob Chemother; 1990 Jun; 25(6):985-93. PubMed ID: 2142486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
    Del Favero A; Menichetti F; Guerciolini R; Bucaneve G; Baldelli F; Aversa F; Terenzi A; Davis S; Pauluzzi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1126-9. PubMed ID: 2959198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized prospective study of ceftazidime and ciprofloxacin with or without teicoplanin as an empiric antibiotic regimen for febrile neutropenic patients.
    Lim SH; Smith MP; Goldstone AH; Machin SJ
    Br J Haematol; 1990 Dec; 76 Suppl 2():41-4. PubMed ID: 2149051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients.
    Nováková I; Donnelly JP; De Pauw B
    Antimicrob Agents Chemother; 1991 Apr; 35(4):672-8. PubMed ID: 1829879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using teicoplanin for empiric therapy of febrile neutropenic patients with haematological malignancies.
    Menichetti F; Del Favero A; Bucaneve G; Aversa F; Fiorio M
    Br J Haematol; 1990 Dec; 76 Suppl 2():45-8. PubMed ID: 2149052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.
    Micozzi A; Venditti M; Amadori S; Pulsoni A; Tirindelli C; Martino P
    Br J Haematol; 1990 Dec; 76 Suppl 2():19-23. PubMed ID: 2149046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teicoplanin for therapy of gram-positive infections in neutropenic patients.
    Verhagen C; De Pauw BE
    Int J Clin Pharmacol Res; 1987; 7(6):491-8. PubMed ID: 2964418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia.
    Meunier F; Van der Auwera P; Aoun M; Bron D
    Br J Haematol; 1990 Dec; 76 Suppl 2():49-53. PubMed ID: 2149053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of teicoplanin in neutropenic patients: values and limits].
    Espinouse D; Chomarat M
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):552-6. PubMed ID: 2143573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study comparing vancomycin and teicoplanin as second-line empiric therapy for infection in neutropenic patients.
    Cony-Makhoul P; Brossard G; Marit G; Pellegrin JL; Texier-Maugein J; Reiffers J
    Br J Haematol; 1990 Dec; 76 Suppl 2():35-40. PubMed ID: 2149050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teicoplanin in combination therapy for febrile episodes in neutropenic and non-neutropenic paediatric patients.
    Lemerle S; de La Rocque F; Lamy R; Fremaux A; Bernaudin F; Lobut JB; Reinert P
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():113-6. PubMed ID: 2965122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
    Kelsey SM; Collins PW; Delord C; Weinhard B; Newland AC
    Br J Haematol; 1990 Dec; 76 Suppl 2():10-3. PubMed ID: 2149044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic teicoplanin during insertion of Hickman catheters.
    Lim SH; Smith MP; Machin SJ; Goldstone AH
    Br J Haematol; 1990 Dec; 76 Suppl 2():27-9. PubMed ID: 2149048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of serious gram-positive infections with teicoplanin.
    Davies AJ; Stone JM; Synott M
    Drugs Exp Clin Res; 1989; 15(1):29-31. PubMed ID: 2526010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftazidime monotherapy is as effective as ceftazidime combined with gentamicin in the treatment of febrile neutropenic patients.
    Kinsey SE; Machin SJ; Goldstone AH
    J Hosp Infect; 1990 Apr; 15 Suppl A():49-53. PubMed ID: 1971645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.
    Fauser AA; Lang E; Dölken G; Bross KJ; Schmid J; Sörgel F
    Infection; 1991; 19(3):195-200. PubMed ID: 1832419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amikacin plus piperacillin versus ceftazidime as initial therapy in granulocytopenic patients with presumed bacteremia.
    Nováková I; Donnelly P; De Pauw B
    Scand J Infect Dis; 1990; 22(6):705-11. PubMed ID: 2284577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of infections by staphylococci and other gram-positive bacteria with teicoplanin: an open study.
    Pauluzzi S; Del Favero A; Menichetti F; Baratta E; Moretti VM; Di Filippo P; Pasticci MB; Guerciolini R; Patoia L; Frongillo RF
    J Antimicrob Chemother; 1987 Sep; 20(3):431-8. PubMed ID: 2960643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teicoplanin monotherapy of serious infections caused by gram-positive bacteria: a re-evaluation of patients with endocarditis or Staphylococcus aureus bacteraemia from a European open trial.
    Davey PG; Williams AH
    J Antimicrob Chemother; 1991 Apr; 27 Suppl B():43-50. PubMed ID: 1829076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.